Cost-effectiveness analysis of schizophrenia relapse prevention: An economic evaluation of the ZEUS (Ziprasidone-Extended-Use-in-Schizophrenia) study in Spain

  1. Bernardo, M.
  2. Azanza, J.R.
  3. Rubio-Terrés, C.
  4. Rejas, J.
Revue:
Clinical Drug Investigation

ISSN: 1173-2563,  1173-2563

Année de publication: 2006

Volumen: 26

Número: 8

Pages: 447-457

Type: Article

DOI: 10.2165/00044011-200626080-00003 GOOGLE SCHOLAR

Objectifs de Développement Durable

La source de données: Scopus